Feeds:
Posts
Comments

Posts Tagged ‘Steven Gerbsman’

Successful termination of “Prohibitive Executory Real Estate Contract”

Posted in Uncategorized, tagged , , , , , , on February 24, 2009| Leave a Comment »

Steven R. Gerbsman, Principal of Gerbsman Partners, announced today that Gerbsman Partners successfully terminated the executory real estate contract for a US based life science company.

The publically held company, executed a lease for 54,000 square feet of space in San Mateo, California. Due to market conditions and the need to raise additional capital, the company made a strategic decision to reduce its corporate space allocation. Faced with a potential contingent liability in excess of $ 15.5 million, the company retained Gerbsman Partners to assist them in the termination of the executory real estate contract.

About Gerbsman Partners

Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. In the past 60 months, Gerbsman Partners has been involved in maximizing value for 51 Technology, Life Science and Medical Device companies and their Intellectual Property and has restructured/terminated over $770 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception, Gerbsman Partners has been involved in over $2.2 billion of financings, restructurings and M&A transactions.

Gerbsman Partners has offices and strategic alliances in Boston, New York, Washington, DC, San Francisco, Europe and Israel.

Read Full Post »

Emphasys Medical Up For Sale

Posted in Board Of Intellectual Capital, boic, Distressed Intellectual Property, Gerbsman Partners, Intellectual capital, Investments, Life Science, Market research, Strategy, Technology, tagged , , , , , , , , , , , , , , , , , , on February 13, 2009| Leave a Comment »

emphasys-logoEmphasys Medical Inc., a Redwood City, Calif.-based medical device company focused on emphysema, has retained Gerbsman Partners to find a strategic buyer, according to VentureWire. The company canceled an IPO last spring, and before that had raised around $80 million in VC funding. Shareholders include Advanced Technology Ventures (17.8%), Morgenthaler Ventures (13.8%), St. Paul Venture Capital (11.5%) OrbiMed Advisors (13.7%), ABS Ventures (10%), Morgan Stanley Venture Partners (7.4%), Cargill Ventures (6.1%) and Neww Enterprise Associates. www.emphasysmedical.com

Links: peHUB, Biospace, DOW Jones,

Read Full Post »

Chaos Reigns in the PC Industry

Posted in Uncategorized, tagged , , , , , on January 27, 2009| Leave a Comment »

The popularity of netbooks, Acer’s rise, Lenovo’s fall, the struggles of component makers to sell virtually anything — it all makes for a crazy time in the personal computer market these days.

The major PC component suppliers –- companies like Intel, Advanced Micro Devices, Nvidia, Seagate and Western Digital –- are reeling as hardware sales dry up. The credit crunch took its toll on business spending, then American corporations shut down in December in a bid to save money and now companies in China have halted their spending as the Chinese New Year approaches.

As Auguste Richard, a chip analyst with Piper Jaffray, told me, “There is nothing going on right now. This is as dark and deep as it goes, with companies not buying or selling anything.”

Read the full article here.

Read Full Post »

Successful Date Certain M&A of “Business Unit and Intellectual Property”

Posted in Uncategorized, tagged , , , , on January 20, 2009| Leave a Comment »

Steven R. Gerbsman, Principal of Gerbsman Partners and James Skelton, a member of Gerbsman Partners Board of Intellectual Capital, announced today their success in maximizing stakeholder value for a technology company that has been the leading provider of archival storage technology to the global IT market. Gerbsman Partners provided Crisis Management leadership, facilitated the sale of the business unit, associated Intellectual Property and assets and recovered substantial receivables. Due to market conditions, the senior lender made the strategic decision to maximize the value of the business unit and Intellectual Property. Gerbsman Partners provided leadership to the company with:

  • Crisis Management and Technology experience in developing the strategic action plans for maximizing value of the business unit, Intellectual Property and assets;
  • Proven domain expertise in maximizing the value of the business unit and Intellectual Property through a targeted and proprietary Date Certain M&A plan;
  • The ability to “Manage the Process” among potential Acquirers, Lawyers, Creditors Management and Advisors;
  • The proven ability to “Drive” toward successful closure for all parties at interest.

About Gerbsman Partners

Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. In the past 60 months, Gerbsman Partners has been involved in maximizing value for 51 Technology, Life Science and Medical Device companies and their Intellectual Property and has restructured/terminated over $770 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception, Gerbsman Partners has been involved in over $2.2 billion of financings, restructurings and M&A transactions.

Gerbsman Partners has offices and strategic alliances in Boston, New York, Washington, DC, San Francisco, Europe and Israel.

For more information, please contact: Steve@GerbsmanPartners.com

Read Full Post »

“Maximizing Enterprise Value through Balance Sheet Restructuring”

Posted in Uncategorized, tagged , , , , on January 7, 2009| Leave a Comment »

Gerbsman Partners has been involved with numerous national and international equity sponsors, senior/junior lenders, investment banks and equipment lessors in the restructuring or termination of various Balance Sheet issues for their portfolio companies. These companies were not necessarily in Crisis, had CASH (in some cases significant CASH) and/or investor groups that were about to provide additional funding. In order stabilize their go forward plan and maximize CASH resources for future growth, there was a specific need to address the Balance Sheet and Contingent Liability issues as soon as possible.

Some of the areas in which Gerbsman Partners has assisted these companies have been in the termination, restructuring and/or reduction of:

  • Prohibitive executory real estate leases, computer and hardware related leases and senior sub-debt obligations – Gerbsman Partners was the “Innovator” in creating strategies to terminate or restructure prohibitive real estate leases, computer and hardware related leases and senior and sub-debt obligations. To date, Gerbsman Partners has terminated or restructured over $750 million of such obligations. These 75 deals were a mixture of both public and private companies, and allowed the restructured company to return to a path of financial viability.
  • Accounts Trade payable obligations – Companies in a crisis, turnaround or restructuring situation typically have accounts and trade payable obligations that become prohibitive for the viability of the company on a go forward basis. Gerbsman Partners has successfully negotiated mutually beneficial restructurings that allowed all parties to maximize enterprise value based on the reality and practicality of the situation.

About Gerbsman Partners

Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. In the past 60 months, Gerbsman Partners has been involved in maximizing value for 50 Technology, Life Science and Medical Device companies and their Intellectual Property and has restructured/terminated over $750 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception, Gerbsman Partners has been involved in over $2.2 billion of financings, restructurings and M&A transactions.

Gerbsman Partners has offices and strategic alliances in Boston, New York, Washington, DC, San Francisco, Europe and Israel.

For more information, please contact Steven Gerbsman at steve@gerbsmanpartners.com

Read Full Post »

« Newer Posts - Older Posts »